Your cart is currently empty!
Mounjaro (Tirzepatide) Injection 5mg | Weight Loss & Diabetes Management
Price:-
$250.00
(Please note: Price shown is per box.)
Product Description
Mounjaro (Tirzepatide) Injection is an advanced dual GIP and GLP-1 receptor agonist developed by Eli Lilly. It?s prescribed for managing type 2 diabetes and has shown significant benefits in reducing body weight. Each prefilled pen contains 5 mg/0.5 mL for once-weekly subcutaneous use. It helps improve glycemic control, insulin sensitivity, and supports sustainable weight loss when combined with diet and exercise.
Key Features & Benefits:
Dual-action: Targets both GIP and GLP-1 receptors
Easy-to-use prefilled injection pen
Approved for Type 2 Diabetes and Weight Loss Support
Promotes significant fat loss & appetite suppression
Once-weekly dosage for better compliance
Manufactured by Eli Lilly
Dosage & Usage Instructions:
Start with 2.5 mg once weekly for 4 weeks (not shown here but typical initiation).
Increase to 5 mg once weekly as maintenance or per medical advice.
Administer subcutaneously in the abdomen, thigh, or upper arm.
Do not reuse pens; dispose of properly after use.
Consult your physician before starting or changing dosage.
Product Description
Mounjaro (Tirzepatide) Injection is an advanced dual GIP and GLP-1 receptor agonist developed by Eli Lilly. It?s prescribed for managing type 2 diabetes and has shown significant benefits in reducing body weight. Each prefilled pen contains 5 mg/0.5 mL for once-weekly subcutaneous use. It helps improve glycemic control, insulin sensitivity, and supports sustainable weight loss when combined with diet and exercise.
Key Features & Benefits:
Dual-action: Targets both GIP and GLP-1 receptors
Easy-to-use prefilled injection pen
Approved for Type 2 Diabetes and Weight Loss Support
Promotes significant fat loss & appetite suppression
Once-weekly dosage for better compliance
Manufactured by Eli Lilly
Dosage & Usage Instructions:
Start with 2.5 mg once weekly for 4 weeks (not shown here but typical initiation).
Increase to 5 mg once weekly as maintenance or per medical advice.
Administer subcutaneously in the abdomen, thigh, or upper arm.
Do not reuse pens; dispose of properly after use.
Consult your physician before starting or changing dosage.